CARDARINE GW501516

PPARδ Agonist for Metabolic & Endurance Research

Alpha Labs Cardarine (also known as GW501516 or Endurobol) is a research‑grade small molecule that acts as a selective agonist of the **peroxisome proliferator‑activated receptor delta (PPARδ)**. It is widely studied in controlled laboratory settings for its potential effects on **energy metabolism, fatty acid oxidation, and endurance signalling**. Cardarine is not a selective androgen receptor modulator (SARM) but a metabolic signalling compound used strictly for research purposes. 

Main Research Benefits of Cardarine (GW501516)

• Supports research into **fatty acid oxidation and energy metabolism** through PPARδ activation. 
• May help investigate **endurance‑linked pathways** and metabolic flexibility in controlled models.
• Explores gene expression changes related to oxidative metabolism and lipid utilisation. 
• Used to study complex metabolic signalling networks influencing energy homeostasis. 
• Cardarine’s activation of the PPARδ pathway has been shown in research to influence gene transcription related to **fatty acid catabolism**, energy balance, and metabolic regulation in skeletal muscle cells and other tissues. 

How Cardarine Works (Research Mechanism)

GW501516 binds selectively to the **PPARδ nuclear receptor**, a transcription factor that regulates genes involved in **lipid metabolism and energy utilisation**. This activation increases the expression of proteins linked to fatty acid oxidation, mitochondrial function, and metabolic efficiency in laboratory studies. }

Rather than acting on androgen receptors (as SARMs do), Cardarine works through metabolic signalling pathways that *reprogram cellular metabolism*, potentially enhancing oxidative capacity and energy expenditure in research models. 

Product Features & Specifications

• Brand: Alpha Labs
• Compound: Cardarine (GW501516)
• Form: Capsules (dose confirmed on label)
• Mechanism: PPARδ agonist targeting metabolic signalling
• Use: Laboratory and scientific research only — not approved for human or veterinary use

Suggested Research Usage

In laboratory research protocols, Cardarine is often incorporated into metabolic or endurance‑focused studies to explore its effects on **fatty acid oxidation, gene expression, and energy regulation pathways**. Dosing schedules depend on experimental design and desired signalling effects.

⚠️ Important: Alpha Labs Cardarine (GW501516) is intended strictly for research use only. It is *not* approved as a dietary supplement, therapeutic drug, or for human or veterinary consumption, and is banned in professional sport by anti‑doping agencies such as WADA. 

Frequently Asked Questions

What is Cardarine (GW501516)?

Cardarine — also referred to as GW501516 — is a **PPARδ agonist** originally developed in the 1990s as a potential therapeutic for metabolic disorders. It influences cellular energy metabolism and fatty acid utilisation in laboratory models.

How is Cardarine different from SARMs?

While SARMs (like Ostarine or RAD140) interact with androgen receptors to influence anabolic pathways, Cardarine **does not bind androgen receptors**. Instead it activates the **PPARδ receptor**, a nuclear receptor that affects metabolic gene transcription and energy regulation. 

Does Cardarine improve endurance in research settings?

Preclinical research suggests that activating PPARδ with GW501516 can enhance markers of **fatty acid oxidation and metabolic efficiency**, which are associated with improved endurance signalling in controlled experimental models.

Is Cardarine approved for human use?

No — Cardarine is *not approved* for human or veterinary use by any major regulatory authority. Clinical development was discontinued due to safety concerns observed in long‑term animal studies, and it is banned by anti‑doping agencies. 

Explore metabolic and energy regulation research pathways with Alpha Labs Cardarine (GW501516) — a high‑purity research compound formulated for scientific study of PPARδ‑mediated signalling, lipid metabolism, and endurance‑associated pathways.